Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10389232 | 0.81 | KDM4E (0.50) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL11211293 | 0.77 | APOBEC3G (0.58) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL182738 | 0.77 | LMNA (0.67) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL26413509 | 0.77 | APOBEC3G (0.58) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| Hydrochloric Acid SCHEMBL19211700 | 0.75 | LMNA (0.64) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| Hydrochloric Acid SCHEMBL1017218 | 0.75 | LMNA (0.64) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| Water SCHEMBL28154432 | 0.75 | LMNA (0.64) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL28206995 | 0.74 | APOBEC3G (0.45) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL7764047 | 0.73 | APOBEC3G (0.54) | APOBEC3GHSD11B1KMT2AMEN1KDM4E | |
| SCHEMBL2372572 | 0.73 | APOBEC3G (0.54) | APOBEC3GHSD11B1KMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169639-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2022-06-02 | — | — | US | claimed |
| EP-3894402-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-20 | — | — | EP | claimed |
| CN-113286792-A | N-containing chromen-4-one derivatives for the treatment and prevention of hepatitis B virus infection | 豪夫迈·罗氏有限公司 | 2021-08-20 | — | — | CN | claimed |
| WO-2020120528-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-18 | — | — | WO | claimed |
| EP-3894402-B1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2023-07-05 | — | — | EP | disclosed |
| US-20220169639-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2022-06-02 | — | — | US | disclosed |
| EP-3894402-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2021-10-20 | — | — | EP | disclosed |
| CN-113286792-A | N-containing chromen-4-one derivatives for the treatment and prevention of hepatitis B virus infection | 豪夫迈·罗氏有限公司 | 2021-08-20 | — | — | CN | disclosed |
| WO-2020120528-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-18 | — | — | WO | disclosed |
| EP-2411475-A1 | PIGMENT DISPERSION, COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF MANUFACTURING THE SAME | FUJIFILM Corporation (JP) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010110491-A1 | PIGMENT DISPERSION, COLORED CURABLE COMPOSITION, COLOR FILTER AND METHOD OF MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | WO | disclosed |
| EP-2197859-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | Fujifilm Corporation (JP) | 2010-06-23 | — | — | EP | disclosed |
| EP-1709483-A4 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL AND COLOR IMAGE-FORMING METHOD | FUJIFILM CORP (JP) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006132404-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJI FILM CORPORATION (JP) | 2006-12-14 | — | — | WO | disclosed |
| EP-1718706-A1 | DYE, INK, INK JET RECORDING METHOD, INK SHEET, COLOR TONER AND COLOR FILTER | FUJI PHOTO FILM CO., LTD. (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1709483-A1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL AND COLOR IMAGE-FORMING METHOD | FUJI PHOTO FILM CO., LTD. (JP) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005075573-A1 | DYE, INK, INK JET RECORDING METHOD, INK SHEET, COLOR TONER AND COLOR FILTER | FUJI PHOTO FILM CO., LTD. (JP) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005073804-A1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL AND COLOR IMAGE-FORMING METHOD | FUJI PHOTO FILM CO., LTD. (JP) | 2005-08-11 | — | — | WO | disclosed |
| US-4230704-A | BACTERICIDES, FUNGICIDES, ALGICIDES | ROHM AND HAAS COMPANY (US) | 1980-10-28 | — | — | US | disclosed |
| US-4169949-A | BACTERICIDES, FUNGICIDES, ANGICIDES, PESTICIDES | ROHM AND HAAS COMPANY (US) | 1979-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169639-A1 | N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HAVCR2, NR0B1, CYP7A1 | APOBEC3G 1054/4885HSD11B1 287/4885KMT2A 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.